China's Psibot just hit a $1.48 billion valuation with automaker Chery leading the round — and it's selling the robot brain, not the robot.
China's Z.AI switched on a 1-gigawatt AI data center running 10,000+ chip clusters with zero Nvidia silicon — the exact build US export controls were designed to prevent.
Valar Atomics tripled to a $6B valuation in four months, with Sequoia set to lead a $1B round — after a 27-year-old dropout's reactor powered a live Nvidia AI chip.
In June 2026, 90,000 AI-generated tracks hit Deezer every day — over half of all new uploads. But they're just 1-3% of streams, and 85% of their plays are fraudulent.
Travis Kalanick's new company Atoms just raised $1.7 billion in an a16z-led round for industrial AI — and Uber, the company that fired him in 2017, is one of the backers.
Socure raised $156M at a $5.2B valuation and bought agentic-AI startup Fravity to fight machine-speed fraud with AI agents of its own.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.
